The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Von Willebrand Factor (VWF) - Drugs in Development, 2021
US$ 3,000.00
Von Willebrand Factor (VWF) - Drugs in Development, 2021 SUMMARY Von Willebrand Factor (VWF) - Drugs in Development, 2021 provides in depth analysis on Von Willebrand Factor (VWF) targeted pipeline th...
April 2021
35 pages
Vulvar Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Vulvar Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Vulvar Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Vulvar Cancer pipeline landscape. The report provides co...
April 2021
80 pages
Wnt Protein (WNT) - Drugs in Development, 2021
US$ 3,000.00
Wnt Protein (WNT) - Drugs in Development, 2021 SUMMARY Wnt Protein (WNT) - Drugs in Development, 2021 provides in depth analysis on Wnt Protein (WNT) targeted pipeline therapeutics. The report provide...
April 2021
35 pages
Investigation Report on China's Ibrutinib Market 2021-2025
US$ 2,600.00
Ibrutinib is a BTK inhibitor, mainly used to treat B-cell carcinomas, such as mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia. Ibrutinib was first developed by...
April 2021
40 pages
Investigation Report on China's Iodixanol Market 2021-2025
US$ 2,600.00
Iodixanol is a third-generation contrast agent that has good solubility and is isotonic to plasma. It is used for cardiovascular angiography, cerebrovascular angiography, abdominal angiography, and so...
April 2021
50 pages
Investigation Report on China's Meropenem Market 2021-2025
US$ 2,600.00
Meropenem is an antibiotic that is used to treat a variety of bacterial infections, including meningitis, pneumonia and so on. Meropenem is jointly developed by Sumitomo Dainippon Pharma and Imperial...
April 2021
50 pages
Investigation Report on China's Nivolumab Market 2021-2025
US$ 2,600.00
Nivolumab is a human IgG4 monoclonal antibody that blocks PD-1, mainly used to treat non-small cell lung cancer, gastric or gastroesophageal junction adenocarcinoma, advanced renal cell carcinoma, and...
April 2021
50 pages
Investigation Report on China's Rituximab Market 2021-2025
US$ 2,600.00
Rituximab is a monoclonal antibody to target cells that have the CD20 marker on their surface. It is mainly used to treat diseases caused by excessive B lymphocytes, including lymphoma, chronic lympho...
April 2021
50 pages
Investigation Report on China's Tacrolimus Market 2021-2025
US$ 2,600.00
Tacrolimus is a macrolide antibiotic and is also a new immunosuppressant. It is available in a variety of dosage forms. The ointment is used for moderate to severe atopic dermatitis where traditional...
April 2021
50 pages
Investigation Report on Chinese Atorvastatin Market 2021-2025
US$ 2,600.00
... demand for Atorvastatin. TOPICS COVERED: Development environment of Atorvastatin in China Sales of Atorvastatin in China Prices of Atorvastatin in China Major Atorvastatin manufacturers in China Market share of Atorvastatin by dosage form in China Prospect of Chinese Atorvastatin Market, 2018-2022 ...
April 2021
50 pages
Investigation Report on China's Ambroxol Market, 2021-2025
US$ 2,600.00
... Pharmaceutical (Qianshan) Co., Ltd. Ambroxol is sold in China in the dosage forms of ... China Size of China's Ambroxol market Competitive landscape of China's Ambroxol market Prices of Ambroxol in China Analysis on factors affecting the development of China's Ambroxol market Prospect of China's Ambroxol ...
April 2021
50 pages
Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025
US$ 2,600.00
... market in China Market size of Recombinant Lispro Insulin in China Major Recombinant Lispro Insulin manufacturers in China Prices of Recombinant Lispro Insulin in China Major factors affecting the development of China's Recombinant Lispro Insulin market Prospect of China's Recombinant Lispro Insulin market
April 2021
50 pages
Investigation Report on Chinese Apixaban Market 2021-2025
US$ 2,600.00
Anticoagulation therapy plays an important role in the prevention and treatment of thromboembolic diseases. The two most famous drugs are Rivaroxaban and Apixaban, mainly used to prevent and treat ven...
April 2021
50 pages
